» Articles » PMID: 12716733

Guidelines for Intervention Trials in Subjects with Newly Diagnosed Type 1 Diabetes

Overview
Journal Diabetes
Specialty Endocrinology
Date 2003 Apr 30
PMID 12716733
Citations 33
Authors
Affiliations
Soon will be listed here.
Citing Articles

Quantifying beta cell function in the preclinical stages of type 1 diabetes.

Galderisi A, Carr A, Martino M, Taylor P, Senior P, Dayan C Diabetologia. 2023; 66(12):2189-2199.

PMID: 37712956 PMC: 10627950. DOI: 10.1007/s00125-023-06011-5.


Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial.

Yan X, Li X, Liu B, Huang J, Xiang Y, Hu Y Signal Transduct Target Ther. 2023; 8(1):158.

PMID: 37076476 PMC: 10115841. DOI: 10.1038/s41392-023-01369-9.


Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy.

Gabbay M, Crispim F, Dib S Diabetol Metab Syndr. 2023; 15(1):51.

PMID: 36935525 PMC: 10026390. DOI: 10.1186/s13098-023-01014-z.


Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice.

Lagunas-Rangel F, Koshelev D, Nedorubov A, Kosheleva L, Trukhan V, Rabinovitch A Front Endocrinol (Lausanne). 2022; 13:1028114.

PMID: 36339443 PMC: 9633961. DOI: 10.3389/fendo.2022.1028114.


Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes.

Anderson R, DiMeglio L, Mander A, Dayan C, Linsley P, Herold K Diabetes Care. 2022; 45(10):2189-2201.

PMID: 36150059 PMC: 9911317. DOI: 10.2337/dc22-0308.